We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Blood-based Biomarkers Can Help To Predict Recurrence of Triple Negative Breast Cancer

News   Jul 10, 2020 | Original story from Indiana University School of Medicine

 
Blood-based Biomarkers Can Help To Predict Recurrence of Triple Negative Breast Cancer

This image shows a triple negative breast cancer cell undergoing retraction and apoptosis (cell death) after treatment with a combination of the chemotherapy drug cisplatin and a mitochondrial division inhibitor drug called mdivi-1. Credit: National Cancer Institute/University of Pittsburgh Cancer Institute. Creator: Wei Qian

 
 
Advertisement
 

RELATED ARTICLES

Mass Spectrometry Shows Potential for Rapid SARS-CoV-2 Detection

News

Signature peptides of the SARS-CoV-2 virus in clinical samples (nasopharyngeal swabs) have been detected by mass spectrometry in 3 minutes and without specific reagents. It provides a proof of concept of the use of this method as a possible alternative to PCR, currently the reference method.

READ MORE

Recreating Nature: Chemists Create Synthetic Version of Natural Anti-Cancer Agent

News

Scripps Research chemists Hans Renata, PhD, and Alexander Adibekian, PhD, have discovered a way to efficiently create a synthetic version of a valuable natural compound called cepafungin I, which has shown promise as an anti-cancer agent.

READ MORE

Molecular Switch Turns on Brown Fat Energy Burn

News

An international research team have discovered how to activate brown fat in humans, which may lead to new treatments for type 2 diabetes and obesity.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE